Skip to main content

The Law Offices of Frank R. Cruz Announces Investigation of Synopsys, Inc. (SNPS) on Behalf of Investors

The Law Offices of Frank R. Cruz announces an investigation of Synopsys, Inc. (“Synopsys” or the “Company”) (NASDAQ: SNPS) on behalf of investors concerning the Company’s possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

On April 13, 2022, news outlets reported that Synopsys is under investigation by the U.S. Department of Commerce for possibly passing key technology to banned Chinese companies. Specifically, investigators are looking into whether Synopsys provided chip designs and software to Huawei Technologies Co.’s HiSilicon unit for manufacture at Semiconductor Manufacturing International Corp. (“SMIC”). U.S. companies are barred from selling some types of technology to Huawei and SMIC because they’ve been designated as threats to national security by the Commerce Department’s Bureau of Industry and Security.

On this news, Synopsys’ share price fell $4.11 to close at $306.72 per share on April 13, 2022, thereby injuring investors.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you purchased Synopsys securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.